RxDoctor Payments Data

Douglas Hornberger

Physician Assistant · Loveland, CONPI 1447339536

Payments from drug & device makers

$5,417in general payments, 2019–2025

Across 69 payments — averaging $78.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Aucta Pharmaceuticals, Inc.$1K
  • Livanova USA, Inc.$715
  • EMD Serono, Inc.$249
  • AbbVie$219
  • SK Life Science, Inc.$152
  • plus $555 from 12 others

What the payments were for

  • Speaking & faculty fees$1,20022%
  • Travel & lodging$2,07438%
  • Food & beverage$2,14340%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott22$2,328
Aucta Pharmaceuticals, Inc.2$1,200
Livanova USA, Inc.1$715
EMD Serono, Inc.8$249
AbbVie(2 entities)8$219
SK Life Science, Inc.3$152
Boston Scientific3$94
Argenx US, Inc.3$64
TG Therapeutics, Inc.3$58
Jazz Pharmaceuticals Inc.2$55
Pfizer3$54
UCB, Inc.3$52
Cognoa, Inc.1$50
AstraZeneca2$37
Lundbeck LLC2$28
Amgen1$22
Novartis1$22
Amneal Pharmaceuticals LLC1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,417 in reported general payments places this provider in the 95th percentile of 2,849 physician assistant providers in Colorado.

See all physician assistant providers in Colorado

Medicare billing

Part B allowed, 2024
$116,243
Medicare patients
567
Services billed
1,288

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine28$182,589
VimpatLacosamide14$41,786
AptiomEslicarbazepine Acetate12$30,661
Lacosamide83$25,852
Rasagiline Mesylate103$20,104
QuliptaAtogepant11$12,172
Carbidopa-Levodopa ErCarbidopa/Levodopa187$9,464
Levetiracetam202$9,103
NeuproRotigotine11$8,622
Carbidopa-LevodopaCarbidopa/Levodopa269$8,453
EliquisApixaban12$6,776
Primidone180$6,058
BelsomraSuvorexant13$5,926
Aripiprazole12$5,822
Gabapentin315$5,631

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
UCB, Inc.Vimpat, Neupro$52$50,40825 claims
AbbVieQulipta$219$12,17211 claims
PfizerEliquis$54$6,77612 claims
Amneal Pharmaceuticals LLCPyridostigmine Bromide$21$1,01711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,849 physician assistant providers in Colorado.

Other physician assistant in Loveland

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →